Tempest Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
08.02.24
/
50%
€4.00
Target price
08.02.25
€13.96
Performance (%)
-21.30%
Price
14.05.24
€3.15
Summary
This prediction is currently active. The prediction for Tempest Therapeutics Inc. disappoints with a performance of -21.30%. This prediction currently runs until 08.02.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Tempest Therapeutics Inc. | -2.539% | -2.539% |
iShares Core DAX® | 1.851% | 5.158% |
iShares Nasdaq 100 | 1.573% | 2.589% |
iShares Nikkei 225® | -0.412% | -2.857% |
iShares S&P 500 | 1.128% | 2.485% |
Comments by Jefferies_Financial_ for this prediction
In the thread Tempest Therapeutics Inc. diskutieren
Tempest Therapeutics, Inc. (NASDAQ: TPST) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for TPST provided by MarketBeat